Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Vivos Therapeutics, Inc. (VVOS : NSDQ)

• Company Description    Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado. Number of Employees: 109

• Price / Volume Information    Yesterday's Closing Price: $6.67 Daily Weekly Monthly 20 Day Moving Average: 1,917,084 shares Shares Outstanding: 5.89 (millions) Market Capitalization: $39.28 (millions) Beta: 7.01 52 Week High: $7.95 52 Week Low: $1.97 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 213.15% 201.42% 12 Week 217.62% 167.16% Year To Date 55.48% 45.60%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 7921 SOUTHPARK PLAZA SUITE 210 - LITTLETON,CO 80120 USA ph: 844-672-4357 fax: - jgannon@vivoslife.com http://www.vivos.com

• General Corporate Information    Officers R. Kirk Huntsman - Chief Executive Officer; Co-founder and Chairman o Bradford Amman - Chief Financial Officer Ralph E. Green - Director Anja Krammer - Director Mark F. Lindsay - Director Peer Information Vivos Therapeutics, Inc. (GSAC) Vivos Therapeutics, Inc. (CASI) Vivos Therapeutics, Inc. (ALCD.) Vivos Therapeutics, Inc. (OMNN) Vivos Therapeutics, Inc. (CGPI.) Vivos Therapeutics, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 92859E207 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/13/25 Share - Related Items Shares Outstanding: 5.89 Most Recent Split Date: 10.00 (0.04:1) Beta: 7.01 Market Capitalization: $39.28 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.35 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.54 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 8.91 Price/Cash Flow: - Price / Sales: 2.69 EPS Growth vs. Year Ago Period: 72.39% vs. Previous Quarter: -60.71% Sales Growth vs. Year Ago Period: -11.79% vs. Previous Quarter: -18.44% ROE 06/30/25 - - 03/31/25 - -170.43 12/31/24 - -197.55 ROA 06/30/25 - - 03/31/25 - -77.82 12/31/24 - -76.43 Current Ratio 06/30/25 - - 03/31/25 - 0.77 12/31/24 - 1.50 Quick Ratio 06/30/25 - - 03/31/25 - 0.77 12/31/24 - 1.50 Operating Margin 06/30/25 - - 03/31/25 - -76.82 12/31/24 - -74.09 Net Margin 06/30/25 - - 03/31/25 - -76.82 12/31/24 - -74.09 Pre-Tax Margin 06/30/25 - - 03/31/25 - -76.82 12/31/24 - -74.09 Book Value 06/30/25 - - 03/31/25 - 0.75 12/31/24 - 1.35 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©